Latest News

May 17, 2011
UCSF's inter-school research day is "part of the growing recognition of the importance of interprofessional team learning and research which is key to the translational medicine of the future,” according to Joel Palefsky, who is credited with organizing the event showcasing research from fellows, residents and students from all four professional schools. 
May 16, 2011
UCSF leaders gathered May 11 to acknowledge the impact the earthquake, tsunami and ongoing nuclear crisis has had on people in Japan and to show support of visiting Japanese students and scholars.
May 13, 2011
The campus community is invited to hear about the past, present and future of UCSF's role in combatting HIV/AIDS during a forum on May 17 to mark 30 years of AIDS and the official kick off the University's participation in the 25th annual AIDS Walk San Francisco.
May 11, 2011
As the leading health science campus for the UC system, UCSF is uniquely positioned to offer a new master’s degree program in biomedical imaging, which has greatly progressed in the last decade, increasing the speed and quality of imaging and driving a greater need for advanced education.
May 11, 2011
Each of the deans of graduate education for the 10 UC campuses sent two students who have recently completed work on their doctoral degrees to the state capitol, where lawmakers are embroiled in painful decision-making to address state budget shortfalls.
May 06, 2011
Three UCSF scientists have received grants from the California Institute for Regenerative Medicine to advance their investigations of treatment strategies for degenerative muscle diseases, such as muscular dystrophy, and heart disease, and to determine why human embryonic stem cells are susceptible to forming tumors.
May 06, 2011
The ongoing controversy surrounding the safety of using TASER® electrical stun guns took a new turn today when a team of cardiologists at the University of California, San Francisco announced findings suggesting that much of the current TASER®-related safety research may be biased due to ties to the devices’ manufacturer, TASER International, Inc.
May 05, 2011
Yervoy, a new cancer drug that has been approved for the treatment of late-stage melanoma – and that is being used to treat other cancers in ongoing clinical trials – is based on a strategy for boosting the immune response developed and tested by scientists from UCSF and UC Berkeley.
May 05, 2011
UCSF's basic research over nearly two decades has led to the first novel antitoxin to treat botulism in nearly a century – becoming the first recombinant human therapy to target one of the most dangerous substances known to man and offering a new defense against bioterrorism.
May 04, 2011
Blending state-of-the art technology and cutting-edge design, UCSF’s new cardiovascular research building at Mission Bay integrates basic and clinical research to address important questions in cardiovascular biology and disease. 

Pages